In 2011, the FDA approved a drug that many hoped would be the first step forward in blood thinning medication since Coumadin’s debut in the 1960s: Xarelto.
Created by Johnson & Johnson and Bayer, Xarelto has been responsible for over $3.2 billion in profits for its manufacturers and developers. It has also become Bayer’s top-selling medication ever. Yet despite its successes on paper, the reality is that more than 18,000 ...
continue reading...
Johnson & Johnson and their Ethicon unit face another defective medical device lawsuit in Philadelphia over their transvaginal mesh products. Sharon Beltz claims that she was injured by a pelvic mesh device because of alleged oversights in the manufacturing process. Opening statements have taken place in the city’s Court of Common Pleas.
Nearly five years ago, Johnson & Johnson voluntarily pulled four lines of mesh products from shelves after ...
continue reading...From around September of last year right up until the ball dropped New Year’s Eve, you couldn’t go a day without hearing someone lament just how terrible the year wound up being. From celebrity deaths and other shocking world events to an increasingly hostile political environment, 2016 was the year that everyone simply wanted to forget.
The corporate world had its share of upheaval as well, but continue reading...
A St. Louis jury has rejected a woman’s case that claimed she contracted ovarian and uterine cancer because of long-term use of Johnson & Johnson talcum powder, according to U.S. News. The jury voted 11-1 against the plaintiff, Nora Daniels, who claimed to have used the product continually for three and a half decades.
Previous St. Louis juries had awarded nearly $200 million to plaintiffs in similar suits. ...
continue reading...
Two New Jersey plaintiffs are seeking to reinstate their cases against Johnson & Johnson, claiming they developed ovarian cancer as a result of using the company’s Shower to Shower product line.
Superior Court Judge Nelson Johnson initially threw out the cases of Diana Balderrama and Brandi Carl because he rejected the expert testimony presented on their behalf. In their appeal, the plaintiffs assert Judge Johnson “misapplied ...
continue reading...
Both sides made their case and the decision was left to the jury. That jury came back with its decision and a very powerful message. $30 million was to paid by Johnson & Johnson for damages sustained by the plaintiffs after receiving Pinnacle hip replacement implants. An additional $1 billion was to be paid in punitive damages.
That verdict was just one in a series of losses for the medical ...
continue reading...
